Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
GLP-1 formulations significantly impact a patients appetite and digestion, necessitating changes to their eating habits
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (marketed as Mounjaro) and chronic weight management (marketed as Zepbound)
Together, these advanced formulations deliver visible improvements in skin radiance, hydration, and texture while addressing underlying causes of aging and dullness
Call us on (+31) 070-345-0290 or email [email protected]
US$ 19.98
US$ 27.67
US$ 28.80
US$ 27.54
US$ 23.51
